SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001640334-19-002503
Filing Date
2019-12-02
Accepted
2019-12-02 16:27:26
Documents
4
Period of Report
2019-11-28
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K lxrp_8k.htm 8-K 12036
2 PRESS RELEASE lxrp_ex991.htm EX-99.1 8409
3 lxrp_ex991img3.jpg GRAPHIC 3113
4 lxrp_ex991img4.jpg GRAPHIC 2950
  Complete submission text file 0001640334-19-002503.txt   30308
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

IRS No.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 8-K | Act: 34 | File No.: 000-52138 | Film No.: 191263526
SIC: 1000 Metal Mining